| Cellular senescence mediates fibrotic pulmonary disease MJ Schafer, TA White, K Iijima, AJ Haak, G Ligresti, EJ Atkinson, AL Oberg, ... Nature communications 8 (1), 14532, 2017 | 1228 | 2017 |
| Targeting the leukemic stem cell: the Holy Grail of leukemia therapy N Misaghian, G Ligresti, LS Steelman, FE Bertrand, J Bäsecke, M Libra, ... Leukemia 23 (1), 25-42, 2009 | 246 | 2009 |
| Mechanosensing and fibrosis DJ Tschumperlin, G Ligresti, MB Hilscher, VH Shah The Journal of clinical investigation 128 (1), 74-84, 2018 | 239 | 2018 |
| PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches G Ligresti, L Militello, LS Steelman, A Cavallaro, F Basile, F Nicoletti, ... Cell cycle 8 (9), 1352-1358, 2009 | 235 | 2009 |
| Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis G Campanholle, G Ligresti, SA Gharib, JS Duffield American Journal of Physiology-Cell Physiology 304 (7), C591-C603, 2013 | 232 | 2013 |
| Extracellular matrix: a matter of life and death S Marastoni, G Ligresti, E Lorenzon, A Colombatti, M Mongiat Connective tissue research 49 (3-4), 203-206, 2008 | 214 | 2008 |
| Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance S Hafsi, FM Pezzino, S Candido, G Ligresti, DA Spandidos, Z Soua, ... International journal of oncology 40 (3), 639-644, 2012 | 187 | 2012 |
| The involvement of the transcription factor Yin Yang 1 in cancer development and progression G Castellano, E Torrisi, G Ligresti, G Malaponte, L Militello, AE Russo, ... Cell cycle 8 (9), 1367-1372, 2009 | 170 | 2009 |
| Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis AJ Haak, E Kostallari, D Sicard, G Ligresti, KM Choi, N Caporarello, ... Science translational medicine 11 (516), eaau6296, 2019 | 158 | 2019 |
| A novel three–dimensional human peritubular microvascular system G Ligresti, RJ Nagao, J Xue, YJ Choi, J Xu, S Ren, T Aburatani, ... Journal of the American Society of Nephrology 27 (8), 2370-2381, 2016 | 95 | 2016 |
| Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2 M Mongiat, G Ligresti, S Marastoni, E Lorenzon, R Doliana, A Colombatti Molecular and cellular biology 27 (20), 7176-7187, 2007 | 95 | 2007 |
| Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance JA McCubrey, SL Abrams, G Ligresti, N Misaghian, EWT Wong, ... Leukemia 22 (11), 2080-2090, 2008 | 94 | 2008 |
| MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway E Lorenzon, R Colladel, E Andreuzzi, S Marastoni, F Todaro, ... Oncogene 31 (26), 3136-3147, 2012 | 92 | 2012 |
| COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury RF Nicosia, G Ligresti, N Caporarello, S Akilesh, D Ribatti The American Journal of Pathology 191 (8), 1374-1384, 2021 | 90 | 2021 |
| PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state N Caporarello, JA Meridew, DL Jones, Q Tan, AJ Haak, KM Choi, ... Thorax 74 (8), 749-760, 2019 | 77 | 2019 |
| The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time-and context-dependent inhibitory and stimulatory properties G Ligresti, AC Aplin, BE Dunn, A Morishita, RF Nicosia Public Library of Science 7 (8), e41387, 2012 | 68 | 2012 |
| Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression G Castellano, E Torrisi, G Ligresti, F Nicoletti, G Malaponte, S Travali, ... Cell cycle 9 (3), 557-563, 2010 | 65 | 2010 |
| CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis G Ligresti, N Caporarello, JA Meridew, DL Jones, Q Tan, KM Choi, ... JCI insight 4 (12), 2019 | 63 | 2019 |
| Dicer1 activity in the stromal compartment regulates nephron differentiation and vascular patterning during mammalian kidney organogenesis N Nakagawa, C Xin, AM Roach, N Naiman, SJ Shankland, G Ligresti, ... Kidney international 87 (6), 1125-1140, 2015 | 59 | 2015 |
| Advances in targeting signal transduction pathways JA McCubrey, LS Steelman, WH Chappell, L Sun, NM Davis, SL Abrams, ... Oncotarget 3 (12), 1505, 2012 | 59 | 2012 |
